IART Insider Trading Activity and SEC Form 4 Filings
Trump's trades in IART
From his financial disclosures
$15K+
1 purchase
$15K+
1 sale
Purchase
Mar 30, 2026
Reported 45d later
$15K - $50K
Sale
Feb 26, 2026
Reported 77d later
$15K - $50K
Many orders in these accounts are placed by the account manager.
IART insider trading summary
No open-market insider purchases or sales of Integra Lifesciences Holdings Corp (IART) have been reported on SEC Form 4 in the past 12 months.
Latest IART insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Nov 5, 2025 | Jeffrey A Graves | Director | Buy | $102K (9,000 @ $11.35) |
| Dec 3, 2024 | Eric Schwartz | EVP, Chief Legal Officer & Sec | Sell | $100K (4,070 @ $24.59) |
| Dec 2, 2024 | Michael J. McBreen | EVP & President, CSS | Sell | $41K (1,700 @ $24.16) |
| Aug 19, 2024 | Jeffrey Mosebrook | SVP, Fin & Princ Acct Officer | Sell | $26K (1,191 @ $21.58) |
| May 23, 2024 | Stuart Essig | Exec. Chairman of the Board | Buy | $1.5M (52,641 @ $28.49) |
| May 21, 2024 | Barbara B Hill | Director | Buy | $996K (36,350 @ $27.40) |
| Mar 6, 2024 | Robert T. Davis Jr. | EVP & President, TT | Sell | $305K (8,348 @ $36.59) |
| Aug 9, 2023 | Jeffrey Mosebrook | SVP, Fin & PAO | Sell | $52K (1,177 @ $44.46) |
| Jun 1, 2023 | Eric Schwartz | EVP, Chief Legal Officer & Sec | Buy | $100K (2,640 @ $37.89) |
| Jun 1, 2023 | Witte Jan De | President & CEO | Buy | $300K (7,792 @ $38.50) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.